Tid Tittel Kategori Vedlegg
11.02.2026
13:45
 Nykode Therapeutics – Invitation to Q4 2025 Financial Results Presentation -
1
30.01.2026
22:44
 Nykode Therapeutics - Grant of share options INSIDEHANDEL INS
1
21.01.2026
11:55
 Nykode Therapeutics ASA - Minutes of Extraordinary General Meeting -
1
19.12.2025
14:45
 Nykode Therapeutics to Present Interim Data from the VB-C-03 trial at the 10th International Congress on Innovative Approaches in Head & Neck Oncology (ICHNO) on March 20, 2026 -
1
18.12.2025
07:00
 Nykode Therapeutics ASA - Notice of Extraordinary General Meeting -
1
18.12.2025
07:00
 Nykode Therapeutics Strengthens Board with the Nomination of Dr. Barbara Krebs-Pohl as New Chair of the Board and Dr. John Beadle as Board Member -
1
24.11.2025
16:40
 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider INSIDEHANDEL INS
1
24.11.2025
07:00
 Nykode Therapeutics - Quarterly Report Q3 2025 RAPPORT RAP
1
13.11.2025
08:00
 Nykode Therapeutics – Invitation to Q3 2025 Financial Results Presentation -
1
05.11.2025
07:00
 Nykode Therapeutics to Present Data on the Strength of the Neoantigen Selection Method from Two Clinical Trials at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting -
1
04.11.2025
07:00
 Nykode Therapeutics Strengthens Intellectual Property Portfolio with New U.S. Patent for the Neoantigen Selection Method for VB10.NEO, Nykode’s Individualized Neoantigen Therapy -
1
10.10.2025
17:44
 Nykode Therapeutics – Grant of Share Options INSIDEHANDEL INS
1
10.10.2025
14:00
 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider INSIDEHANDEL INS
1
10.10.2025
12:36
 Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider INSIDEHANDEL INS
1